MS
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Norges
· Exited
−$1.1B
Change
−2.5M
Δ Own
−100.0%
Date
Q1 2026
|
Norges | Exited· Q1 2026 | −$1.1B | −2.5M | −100.0% | Q1 2026 | |||||
|
Aristotle Capital Management, LLC
· New
+$981M
Change
+2.3M
Date
Q1 2026
|
Aristotle Capital Management, LLC | New· Q1 2026 | +$981M | +2.3M | – | Q1 2026 | |||||
|
D. E. Shaw & Co., Inc.
· Reduced
−$530M
Change
−1.2M
Δ Own
−93.0%
Date
Q1 2026
|
D. E. Shaw & Co., Inc. | Reduced· Q1 2026 | −$530M | −1.2M | −93.0% | Q1 2026 | |||||
|
Goldman Sachs Group Inc
· Added
+$396M
Change
+916K
Date
Q1 2026
|
Goldman Sachs Group Inc | Added· Q1 2026 | +$396M | +916K | – | Q1 2026 | |||||
|
Capital World Investors
· Reduced
−$295M
Change
−682K
Date
Q1 2026
|
Capital World Investors | Reduced· Q1 2026 | −$295M | −682K | – | Q1 2026 | |||||
|
Two Sigma Advisers, LP
· Exited
−$256M
Change
−591K
Δ Own
−100.0%
Date
Q1 2026
|
Two Sigma Advisers, LP | Exited· Q1 2026 | −$256M | −591K | −100.0% | Q1 2026 | |||||
|
Orbis Allan Gray Ltd
· Added
+$254M
Change
+587K
Date
Q1 2026
|
Orbis Allan Gray Ltd | Added· Q1 2026 | +$254M | +587K | – | Q1 2026 | |||||
|
Ameriprise Financial Inc
· Added
+$251M
Change
+580K
Date
Q1 2026
|
Ameriprise Financial Inc | Added· Q1 2026 | +$251M | +580K | – | Q1 2026 | |||||
|
Voloridge Investment Management, LLC
· Exited
−$246M
Change
−567K
Δ Own
−100.0%
Date
Q1 2026
|
Voloridge Investment Management, LLC | Exited· Q1 2026 | −$246M | −567K | −100.0% | Q1 2026 | |||||
|
First Trust Advisors LP
· Reduced
−$219M
Change
−505K
Date
Q1 2026
|
First Trust Advisors LP | Reduced· Q1 2026 | −$219M | −505K | – | Q1 2026 | |||||
|
Holocene Advisors, LP
· Added
+$189M
Change
+436K
Date
Q1 2026
|
Holocene Advisors, LP | Added· Q1 2026 | +$189M | +436K | – | Q1 2026 | |||||
|
Schwab
· Added
+$188M
Change
+434K
Date
Q1 2026
|
Schwab | Added· Q1 2026 | +$188M | +434K | – | Q1 2026 | |||||
|
Qube Research & Technologies Ltd
· Reduced
−$180M
Change
−416K
Date
Q1 2026
|
Qube Research & Technologies Ltd | Reduced· Q1 2026 | −$180M | −416K | – | Q1 2026 | |||||
|
Squarepoint Ops LLC
· Reduced
−$166M
Change
−384K
Date
Q1 2026
|
Squarepoint Ops LLC | Reduced· Q1 2026 | −$166M | −384K | – | Q1 2026 | |||||
|
T. Rowe Price Associates
· Added
+$166M
Change
+383K
Date
Q1 2026
|
T. Rowe Price Associates | Added· Q1 2026 | +$166M | +383K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lashier Mark E.
· Director
Grant (A)
$28K
|
Lashier Mark E. | Director | Grant (A) | $422.66 | 66 | $28K | 1K | +6.7% | Jul 3, 2026 | Jul 7, 2026 | |||||||||
|
Niewiara James A.
· Officer
Gift (G)
-166
|
Niewiara James A. | Officer | Gift (G) | – | -166 | – | 20K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Tucci Joseph M.
· Director
Grant (A)
598
|
Tucci Joseph M. | Director | Grant (A) | – | 598 | – | 14K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Mann Elizabeth
· Director
Grant (A)
598
|
Mann Elizabeth | Director | Grant (A) | – | 598 | – | 2K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Leav Peter
· Director
Grant (A)
598
|
Leav Peter | Director | Grant (A) | – | 598 | – | 643 | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Lashier Mark E.
· Director
Grant (A)
598
|
Lashier Mark E. | Director | Grant (A) | – | 598 | – | 986 | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Howard Ayanna
· Director
Grant (A)
598
|
Howard Ayanna | Director | Grant (A) | – | 598 | – | 4K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Denman Kenneth D.
· Director
Grant (A)
598
|
Denman Kenneth D. | Director | Grant (A) | – | 598 | – | 8K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Anasenes Nicole
· Director
Grant (A)
598
|
Anasenes Nicole | Director | Grant (A) | – | 598 | – | 2K | – | May 18, 2026 | May 20, 2026 | |||||||||
|
Mondre Greg
· Director
Grant (A)
$28K
|
Mondre Greg | Director | Grant (A) | $438.96 | 63 | $28K | 2K | – | Apr 3, 2026 | Apr 7, 2026 | |||||||||
|
Lashier Mark E.
· Director
Grant (A)
$28K
|
Lashier Mark E. | Director | Grant (A) | $438.96 | 63 | $28K | 387 | – | Apr 3, 2026 | Apr 7, 2026 | |||||||||
|
Brown Gregory Q.
· Director, Officer
2 operations
3K
|
Brown Gregory Q. | Director, Officer | 2 operations | – | 3K | – | 6K | – | Mar 14, 2026 | Mar 16, 2026 | |||||||||
|
Brown Gregory Q.
· Director, Officer
Tax withholding or exercise payment (F)
-$2.0M
|
Brown Gregory Q. | Director, Officer | Tax withholding or exercise payment (F) | $473.12 | -4K | -$2.0M | 85K | – | Mar 14, 2026 | Mar 16, 2026 | |||||||||
|
Maher Katherine A.
· Officer
Tax withholding or exercise payment (F)
-$28K
|
Maher Katherine A. | Officer | Tax withholding or exercise payment (F) | $473.12 | -59 | -$28K | 1K | – | Mar 14, 2026 | Mar 16, 2026 | |||||||||
|
Molloy John P.
· Officer
2 operations
548
|
Molloy John P. | Officer | 2 operations | – | 548 | – | 1K | – | Mar 14, 2026 | Mar 16, 2026 | |||||||||
1,359 reporting institutions disclosed MSI position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.